This analysis highlights adverse reactions to cycloplegic agents in ocular treatments, suggesting management strategies.
A minimum clinical history and examination preceding drug instillation is described. Clinically effective doses of topically applied cycloplegic agents are summarized. A presentation of the causes and incidence of adverse drug reactions, both systemic and ocular, is followed by a discussion of general guidelines for their prevention or management.
No takes yet. Share an insight, caveat, or question.
Jimmy D. Bartlett (1978) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: